Nuchido

Nuchido is a Newcastle, UK longevity company founded in 2017 by molecular biologist and CEO Dr. Nichola Conlon, who earned her PhD in physiology from Newcastle University. Rather than dosing a single NAD+ precursor, Nuchido takes a systems-pharmacology approach with its flagship Nuchido TIME+ supplement, which combines multiple ingredients intended to address several root causes of age-related NAD+ decline at once and reactivate the body's natural NAD+ production. The company's scientific advisory board has included biogerontologist Tom Kirkwood, and a 2024 study in npj Aging reported on its systems approach to raising NAD+ in human participants.